ImmuCell Corporation Liabilities Subject to Compromise, Early Contract Termination Fees
ImmuCell Corporation (ICCC) had Liabilities Subject to Compromise, Early Contract Termination Fees of $100.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Notes
us-gaap:LiabilitiesSubjectToCompromiseEarlyContractTerminationFees · last filed 2019-08-12
- 2019-06-30: Liabilities Subject to Compromise, Early Contract Termination Fees $100.00K.
- 2019-03-31: Liabilities Subject to Compromise, Early Contract Termination Fees $100.00K.
- 2018-12-31: Liabilities Subject to Compromise, Early Contract Termination Fees $100.00K.
- 2018-09-30: Liabilities Subject to Compromise, Early Contract Termination Fees $100.00K.
| Period end | Liabilities Subject to Compromise, Early Contract Termination Fees |
|---|---|
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $100.00K 10-K · filed 2019-03-22 |
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $100.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $100.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $100.00K 10-K · filed 2018-03-29 |
| 2017-09-30 | $100.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $100.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $100.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $100.00K 10-K · filed 2017-03-30 |
| 2016-09-30 | $100.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $100.00K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |